
Louise Wang Zhiying Humphrey
Supervisory Patent Examiner (ID: 4289, Phone: (571)272-5543 , Office: P/1657 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1657, 1648 |
| Total Applications | 627 |
| Issued Applications | 267 |
| Pending Applications | 54 |
| Abandoned Applications | 312 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6530526
[patent_doc_number] => 20100221242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'ANTI-VIRAL GRIFFITHSIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/095697
[patent_app_country] => US
[patent_app_date] => 2006-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 29108
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221242.pdf
[firstpage_image] =>[orig_patent_app_number] => 12095697
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095697 | Anti-viral griffithsin compounds, compositions and methods of use | Nov 30, 2006 | Issued |
Array
(
[id] => 5135628
[patent_doc_number] => 20070077257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Enhanced first generation adenovirus vaccines expressing condon optimized HIV1-Gag, Pol, Nef and modifications'
[patent_app_type] => utility
[patent_app_number] => 11/604553
[patent_app_country] => US
[patent_app_date] => 2006-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 177
[patent_figures_cnt] => 177
[patent_no_of_words] => 40459
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20070077257.pdf
[firstpage_image] =>[orig_patent_app_number] => 11604553
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/604553 | Enhanced first generation adenovirus vaccines expressing condon optimized HIV1-Gag, Pol, Nef and modifications | Nov 26, 2006 | Abandoned |
Array
(
[id] => 4954530
[patent_doc_number] => 20080187554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'Process for producing stable HIV Th-CTL peptides'
[patent_app_type] => utility
[patent_app_number] => 11/592404
[patent_app_country] => US
[patent_app_date] => 2006-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 3941
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20080187554.pdf
[firstpage_image] =>[orig_patent_app_number] => 11592404
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/592404 | Process for producing stable HIV Th-CTL peptides | Nov 2, 2006 | Abandoned |
Array
(
[id] => 4443890
[patent_doc_number] => 07862820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-04
[patent_title] => 'Immunoglobulin chimeric monomer-dimer hybrids'
[patent_app_type] => utility
[patent_app_number] => 11/588431
[patent_app_country] => US
[patent_app_date] => 2006-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 40
[patent_no_of_words] => 36924
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/862/07862820.pdf
[firstpage_image] =>[orig_patent_app_number] => 11588431
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/588431 | Immunoglobulin chimeric monomer-dimer hybrids | Oct 26, 2006 | Issued |
Array
(
[id] => 5219670
[patent_doc_number] => 20070160981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'VIRAL PROTEASE'
[patent_app_type] => utility
[patent_app_number] => 11/551789
[patent_app_country] => US
[patent_app_date] => 2006-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12507
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20070160981.pdf
[firstpage_image] =>[orig_patent_app_number] => 11551789
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/551789 | VIRAL PROTEASE | Oct 22, 2006 | Abandoned |
Array
(
[id] => 9625999
[patent_doc_number] => 08795674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-05
[patent_title] => 'Methods and compositions for modulating immune tolerance'
[patent_app_type] => utility
[patent_app_number] => 11/992880
[patent_app_country] => US
[patent_app_date] => 2006-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 60
[patent_no_of_words] => 20814
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11992880
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/992880 | Methods and compositions for modulating immune tolerance | Sep 27, 2006 | Issued |
Array
(
[id] => 5316444
[patent_doc_number] => 20090281042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'COMPOSITIONS AND METHODS USING SAME FOR THE DETECTION OF VIRUSES'
[patent_app_type] => utility
[patent_app_number] => 12/066312
[patent_app_country] => US
[patent_app_date] => 2006-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 30718
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20090281042.pdf
[firstpage_image] =>[orig_patent_app_number] => 12066312
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/066312 | COMPOSITIONS AND METHODS USING SAME FOR THE DETECTION OF VIRUSES | Sep 9, 2006 | Abandoned |
Array
(
[id] => 4704140
[patent_doc_number] => 20080063664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'High-yield transgenic mammalian expression system for generating virus-like particles'
[patent_app_type] => utility
[patent_app_number] => 11/515843
[patent_app_country] => US
[patent_app_date] => 2006-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7751
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20080063664.pdf
[firstpage_image] =>[orig_patent_app_number] => 11515843
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/515843 | High-yield transgenic mammalian expression system for generating virus-like particles | Sep 4, 2006 | Abandoned |
Array
(
[id] => 5520847
[patent_doc_number] => 20090028828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'Rotavirus Vaccine Inducing Heterotypic Cross Protection'
[patent_app_type] => utility
[patent_app_number] => 12/063602
[patent_app_country] => US
[patent_app_date] => 2006-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 20707
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20090028828.pdf
[firstpage_image] =>[orig_patent_app_number] => 12063602
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/063602 | Rotavirus Vaccine Inducing Heterotypic Cross Protection | Aug 14, 2006 | Abandoned |
Array
(
[id] => 5052090
[patent_doc_number] => 20070032635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes'
[patent_app_type] => utility
[patent_app_number] => 11/504974
[patent_app_country] => US
[patent_app_date] => 2006-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 27435
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20070032635.pdf
[firstpage_image] =>[orig_patent_app_number] => 11504974
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/504974 | Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes | Aug 14, 2006 | Abandoned |
Array
(
[id] => 6577369
[patent_doc_number] => 20100047276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Recombinant Vectors Based On the Modified Vaccinia Ankara Virus (MVA) as Preventive and Therapeutic Vaccines Against Aids'
[patent_app_type] => utility
[patent_app_number] => 11/989425
[patent_app_country] => US
[patent_app_date] => 2006-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 41994
[patent_no_of_claims] => 120
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047276.pdf
[firstpage_image] =>[orig_patent_app_number] => 11989425
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/989425 | Recombinant vectors based on the modified vaccinia ankara virus (MVA) as preventive and therapeutic vaccines against AIDS | Jul 24, 2006 | Issued |
Array
(
[id] => 5733474
[patent_doc_number] => 20060258591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Compositions and methods of treating HIV infections'
[patent_app_type] => utility
[patent_app_number] => 11/491623
[patent_app_country] => US
[patent_app_date] => 2006-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19483
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258591.pdf
[firstpage_image] =>[orig_patent_app_number] => 11491623
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/491623 | Compositions and methods of treating HIV infections | Jul 23, 2006 | Abandoned |
Array
(
[id] => 263470
[patent_doc_number] => 07569228
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-04
[patent_title] => 'Fusion proteins of non-attenuated HIV regulatory/accessory proteins'
[patent_app_type] => utility
[patent_app_number] => 11/488803
[patent_app_country] => US
[patent_app_date] => 2006-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7644
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/569/07569228.pdf
[firstpage_image] =>[orig_patent_app_number] => 11488803
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/488803 | Fusion proteins of non-attenuated HIV regulatory/accessory proteins | Jul 17, 2006 | Issued |
Array
(
[id] => 6436668
[patent_doc_number] => 20100152601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'ASPIRATION STATE MONITORING DEVICE, ASPIRATION STATE MONITORING SYSTEM, BASE DEVICE, CONTROL SYSTEM, AND CONTROL SYSTEM USE METHOD'
[patent_app_type] => utility
[patent_app_number] => 11/993473
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9018
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152601.pdf
[firstpage_image] =>[orig_patent_app_number] => 11993473
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/993473 | ASPIRATION STATE MONITORING DEVICE, ASPIRATION STATE MONITORING SYSTEM, BASE DEVICE, CONTROL SYSTEM, AND CONTROL SYSTEM USE METHOD | Jun 19, 2006 | Abandoned |
Array
(
[id] => 4873225
[patent_doc_number] => 20080199959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Method For Cell Culture'
[patent_app_type] => utility
[patent_app_number] => 11/917169
[patent_app_country] => US
[patent_app_date] => 2006-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2229
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20080199959.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917169
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917169 | Method For Cell Culture | Jun 18, 2006 | Abandoned |
Array
(
[id] => 8846048
[patent_doc_number] => 08455227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-04
[patent_title] => 'Detection of HIV-1 infection'
[patent_app_type] => utility
[patent_app_number] => 11/922404
[patent_app_country] => US
[patent_app_date] => 2006-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8729
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11922404
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/922404 | Detection of HIV-1 infection | Jun 14, 2006 | Issued |
Array
(
[id] => 7977075
[patent_doc_number] => 08071284
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => 'Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs'
[patent_app_type] => utility
[patent_app_number] => 11/916632
[patent_app_country] => US
[patent_app_date] => 2006-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 22179
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071284.pdf
[firstpage_image] =>[orig_patent_app_number] => 11916632
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/916632 | Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs | Jun 5, 2006 | Issued |
Array
(
[id] => 5699627
[patent_doc_number] => 20060216311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral DNA'
[patent_app_type] => utility
[patent_app_number] => 11/441860
[patent_app_country] => US
[patent_app_date] => 2006-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12448
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216311.pdf
[firstpage_image] =>[orig_patent_app_number] => 11441860
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/441860 | Method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral DNA | May 25, 2006 | Abandoned |
Array
(
[id] => 5337858
[patent_doc_number] => 20090054322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Polypeptides and compositions comprising same and methods of using same for treating cxcr4 associated medical conditions'
[patent_app_type] => utility
[patent_app_number] => 11/920052
[patent_app_country] => US
[patent_app_date] => 2006-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18363
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054322.pdf
[firstpage_image] =>[orig_patent_app_number] => 11920052
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/920052 | Polypeptides and compositions comprising same and methods of using same for treating cxcr4 associated medical conditions | May 24, 2006 | Abandoned |
Array
(
[id] => 4758899
[patent_doc_number] => 20080311125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Scytovirin Domain 1 Related Polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/914833
[patent_app_country] => US
[patent_app_date] => 2006-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13612
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311125.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914833
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914833 | Scytovirin domain 1 related polypeptides | May 23, 2006 | Issued |